BP Lowering-Cancer Link Debunked; Cannabidiol’s Safety; Heart Failure Checkups MIA
Recent developments of interest in cardiovascular medicine
Related Articles
GLP-1 Drugs and Liver Screening Took Center Stage at AACE Meeting
Obesity, diabetes, and metabolic liver disease dominate annual meeting talks
GLP-1 Drugs May Help in Fibromyalgia, Large Records Study Suggests
TikTok points researcher toward signal of benefit
Autistic Doctors Weigh In on ‘Love on the Spectrum’
They praise the show’s warmth, but say it still misses most of the spectrum
Misconceptions Abound Regarding High Blood Pressure, Poll Finds
THURSDAY, June 12, 2025 (HealthDay News) — A good number of people don’t know that high blood pressure is a silent killer, increasing a person’s…
Ultraprocessed Foods Raised Lupus Risk at Least 50% in Women
Higher intake of ultraprocessed foods among women was associated with a >50% higher risk for systemic lupus erythematosus (SLE). That’s the key finding in a…
Anti-Vaxxers on CDC Panel: A Broken Promise From RFK Jr.?
Being called an anti-vaxxer is a compliment, one new ACIP member says
Polypill Approved for Hypertension, Including as Initial Therapy
The pill comes in three doses and contains telmisartan, amlodipine, and indapamide
Surgical Blood Conservation Technique Falls Short in Trial
Red cell transfusion rates, patient outcomes unchanged with acute normovolemic hemodilution
Zap the Skull to Treat Rheumatoid Arthritis Pain?
Electrical stimulation found effective in small randomized trial
Managing IBD Patients Who Don’t Respond, or Can’t Tolerate, Upadacitinib
Upadacitinib (Rinvoq), a selective Janus kinase 1 (JAK1) inhibitor, is an emerging treatment for inflammatory bowel disease (IBD) and is increasingly used in clinical practice.…